Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches

Table 1

Change in serum lipid profile in the normal control (NC), atherogenic control (AC), vehicle control (VC), and clopidogrel treated groups.

Parameters	Groups
	Clopidogrel treated	AC	NC	VC
TC (mg/dL)	1010.30±65.46^N	1017.1±64.94^∗	46.30±0.99	1116.40±42.91^N
TG (mg/dL)	3320±40.23^N	337.10±40.87^∗	60±3.47	357±35.18^N
HDL (mg/dL)	26.10±1.26^N	24.10±1.86^∗	15.70±1.46	22.10±0.77^N
LDL (mg/dL)	917.70±64.98^N	925.60±63.93^∗	18.60±1.46	1022.90±38.77^N
VLDL (mg/dL)	66.40±8.05^N	67.40±8.17^∗	12±0.69	71.40±7.04^N

Results are expressed as mean ± SEM.
^∗𝑃<0.05, as compared to NC group.
^NNot significant as compared to AC group.